Shopping Cart
- Remove All
Your shopping cart is currently empty
Mirvetuximab (M9346A) is a novel folate receptor α (FRα) monoclonal antibody targeting anti-FOLR1 (folate receptor 1). Mirvetuximab soravtansine is often conjugated with platinum compounds or other compounds to form antibody-drug conjugates for the treatment of ovarian cancer and other FRα-positive cancers.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $322 | In Stock | |
| 5 mg | $788 | In Stock | |
| 10 mg | $1,280 | In Stock |
| Description | Mirvetuximab (M9346A) is a novel folate receptor α (FRα) monoclonal antibody targeting anti-FOLR1 (folate receptor 1). Mirvetuximab soravtansine is often conjugated with platinum compounds or other compounds to form antibody-drug conjugates for the treatment of ovarian cancer and other FRα-positive cancers. |
| Synonyms | M9346A |
| Molecular Weight | 148 kDa (average) |
| Cas No. | 1453084-36-0 |
| Color | Transparent |
| Appearance | Liquid |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.